TENAX THERAPEUTICS, INC. Loans Payable, Current
TENAX THERAPEUTICS, INC. (TENX) had Loans Payable, Current of $213.58 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2021-05-17
- 2021-03-31: Loans Payable, Current $213.58K.
| Period end | Loans Payable, Current |
|---|---|
| 2021-03-31 | $213.58K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |